Common Shares Outstanding: The number of class A shares currently held by investors.
Passage Bio, Inc. (PASG) had Common Shares Outstanding of 3.18M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.38M |
|
-- |
|
-- |
|
$10.33M |
|
$-10.33M |
|
$0.95M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-10.33M |
|
$-10.16M |
|
3.17M |
|
3.17M |
|
$-2.96 |
|
$-2.96 |
|
| Balance Sheet Financials | |
$60.31M |
|
$5.34M |
|
$18.88M |
|
$79.20M |
|
$19.80M |
|
-- |
|
$21.14M |
|
$40.94M |
|
$38.26M |
|
$38.26M |
|
$38.26M |
|
|
Common Shares Outstanding |
3.18M |
| Cash Flow Statement Financials | |
$-20.18M |
|
$40.22M |
|
$0.01M |
|
$37.57M |
|
$57.63M |
|
$20.05M |
|
$1.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.53% |
|
-24.53% |
|
-11.85% |
|
-24.53% |
|
$12.03 |
|
$-6.00 |
|
$-6.37 |
|